Cullgen Inc. Alternatives & Competitors
12 companies similar to Cullgen Inc. — Powering protein degradation for tomorrow's medicines
Companies similar to Cullgen Inc.
Avilar Therapeutics
Pioneering the discovery and development of extracellular protein degraders.
Arvinas
Leading the way in targeted protein degradation therapeutics
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
Parabilis Medicines
We are dedicated to creating extraordinary medicines for people affected by serious diseas...
Rival Readout
Competing with Cullgen Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Adcentrx Therapeutics
Merging Chemistry and Biology to Benefit the Lives of Patients
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the diffic...
Differentiated Therapeutics Inc
What if you could predict molecules to make the cause of disease disappear?
FogPharma
Until everything is druggable.
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
DEM Biopharma, Inc.
Novel Target for Solid Tumors
About Cullgen Inc.
Cullgen Inc., founded in 2018, is at the forefront of the biopharmaceutical sector with its pioneering slogan: "Powering protein degradation for tomorrow's medicines." The company is headquartered in the United States and operates in the Biotechnology and Pharmaceutical industries. Leveraging its proprietary uSMITE™ te...
Development of protein degraders, Research in novel E3 ligands, Non-opioid pain treatment solutions, Biopharmaceutical pipeline development
Pharmaceutical industry, Biotech researchers, Healthcare providers, Patients with debilitating diseases
Biopharmaceutical, Protein Degradation Technology, USMITE™, E3 Ligands, Drug Discovery, Cancer Treatment, Inflammatory Diseases, Autoimmune Diseases, Undruggable Targets, Therapeutic Approaches, Intracellular Disease Targets, Novel Treatment, Protein Disposal System, Small Molecule Therapies, Disease-causing Proteins
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Cullgen Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Cullgen Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.